SEC Form 3 · accession 0001437749-18-014341
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Parker K Javid
Officer — Vice President
Period of report
Jul 25, 2018
Accepted (ET)
Aug 2, 2018 · 6:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No Security beneficially owned | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Buy)F5 | $14.35 | holding | — | — | — | — | Jul 25, 2025 | Common Stock | 5,482 | — | D |
| Nonqualified Stock Options (Right to Buy)F5 | $14.35 | holding | — | — | — | — | Jul 25, 2025 | Common Stock | 5,768 | — | D |
| Restricted Stock Units (Right to Buy)F1,F2 | — | holding | — | — | — | — | Jul 25, 2021 | Common Stock | 3,750 | — | D |
| Restricted Stock Units (Right to Buy)F1,F2 | — | holding | — | — | — | — | May 25, 2019 | Common Stock | 10,000 | — | D |
| Nonqualified Stock Options (Right to Buy)F3 | $11.36 | holding | — | — | — | — | May 25, 2023 | Common Stock | 8,208 | — | D |
| Incentive Stock Option (Right to Buy)F3 | $11.36 | holding | — | — | — | — | May 25, 2023 | Common Stock | 21,792 | — | D |
| Restricted Stock Units (Right to Buy)F1,F2 | — | holding | — | — | — | — | Oct 19, 2020 | Common Stock | 5,000 | — | D |
| Nonqualified Stock Options (Right to Buy)F4 | $12.65 | holding | — | — | — | — | Oct 19, 2024 | Common Stock | 6,688 | — | D |
| Incentive Stock Option (Right to Buy)F4 | $12.65 | holding | — | — | — | — | Oct 19, 2024 | Common Stock | 8,312 | — | D |
Explanation of responses
- F1The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis.
- F2Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit.
- F3The options vest as to (a) 33% for first year beginning on May 25, 2017 and then (b) the remaining in 1/36 monthly installments over the following 24 months, subject to continued service through each vesting date.
- F4The options vest as to 1/36 of the total shares monthly, beginning on November 19, 2017, subject to continued service through each vesting date.
- F5The options vest as to 1/36 of the total shares monthly, beginning on August 25, 2018, subject to continued service through each vesting date.